Proliferation assay amplification by IL-2 in model primary and recall antigen systems
It can be difficult to register a weak proliferative response of T lymphocytes to an antigen, particularly in a simple culture system of peripheral blood mononuclear cells (PBMC). Here we assess the usefulness of the cytokine IL-2 in amplifying such a response. PBMC from healthy donors were cultured...
Gespeichert in:
Veröffentlicht in: | BMC research notes 2014-09, Vol.7 (1), p.662-662, Article 662 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 662 |
---|---|
container_issue | 1 |
container_start_page | 662 |
container_title | BMC research notes |
container_volume | 7 |
creator | Kennell, Amy S M Gould, Keith G Salaman, Myer R |
description | It can be difficult to register a weak proliferative response of T lymphocytes to an antigen, particularly in a simple culture system of peripheral blood mononuclear cells (PBMC). Here we assess the usefulness of the cytokine IL-2 in amplifying such a response.
PBMC from healthy donors were cultured in the presence or absence of keyhole limpet haemocyanin (KLH), an antigen to which people have not been previously exposed. IL-2 was added from the beginning or on the fifth day of culture. Proliferation was determined by incorporation of tritiated thymidine at eight days. The recall antigen, tuberculin PPD, provided a positive control.
IL-2 added at the beginning of culture can induce extremely high levels of proliferation even in the absence of antigen. However, when added on the fifth day it allowed the clear observation of a proliferative response to KLH that was barely detectable in its absence. Added late it was similarly able to boost low responses to PPD and to the mitogens lipopolysaccharide and poly(I:C), but it had no such effect with pokeweed mitogen.
IL-2 added late in culture is highly effective in increasing the sensitivity of T lymphocyte proliferative assays. |
doi_str_mv | 10.1186/1756-0500-7-662 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4190572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A540834486</galeid><sourcerecordid>A540834486</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4962-9338cce0f616ce33125e169e1f7640ca3b521eb9cc9ed0def5e6dead7e6eb6093</originalsourceid><addsrcrecordid>eNp1kk1v1DAQhi0EoqVw5oYicYFDWn_EjnNBKlWBlVYqB8rVcpzJ4sqxFztB7L-vo12WBhX54NHMM69Hrweh1wSfEyLFBam5KDHHuKxLIegTdHrMPH0Qn6AXKd1hLIiU5Dk6oZyyBkt8im6_xuBsD1GPNvhCp6R3hR62OWfNPtfuitW6pIX1xRA6cMU22kHHjPmuiGC0czkc7QZ8kXZphCG9RM967RK8Otxn6PbT9berL-X65vPq6nJdtlUjaNkwJo0B3AsiDDBGKAciGiB9LSpsNGs5JdA2xjTQ4Q56DqID3dUgoBW4YWfow153O7UDdAb8GLVThwFV0FYtK97-UJvwS1WkwbymWeDjXqC14T8Cy4oJg5ptVbOtqlbZ9Czy7jBFDD8nSKMabDLgnPYQpqQIl4Jgysk88Nt_0LswRZ89ylSdv0XWnP2lNtqBsr4P-W0zi6pLXmHJqkqKTJ0_QuXTwWBN8NDbnF80vF80ZGaE3-NGTymp1c33JXuxZ00MKUXoj54QrObVe8SFNw__4sj_2TV2D87h0uw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1572528753</pqid></control><display><type>article</type><title>Proliferation assay amplification by IL-2 in model primary and recall antigen systems</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Kennell, Amy S M ; Gould, Keith G ; Salaman, Myer R</creator><creatorcontrib>Kennell, Amy S M ; Gould, Keith G ; Salaman, Myer R</creatorcontrib><description>It can be difficult to register a weak proliferative response of T lymphocytes to an antigen, particularly in a simple culture system of peripheral blood mononuclear cells (PBMC). Here we assess the usefulness of the cytokine IL-2 in amplifying such a response.
PBMC from healthy donors were cultured in the presence or absence of keyhole limpet haemocyanin (KLH), an antigen to which people have not been previously exposed. IL-2 was added from the beginning or on the fifth day of culture. Proliferation was determined by incorporation of tritiated thymidine at eight days. The recall antigen, tuberculin PPD, provided a positive control.
IL-2 added at the beginning of culture can induce extremely high levels of proliferation even in the absence of antigen. However, when added on the fifth day it allowed the clear observation of a proliferative response to KLH that was barely detectable in its absence. Added late it was similarly able to boost low responses to PPD and to the mitogens lipopolysaccharide and poly(I:C), but it had no such effect with pokeweed mitogen.
IL-2 added late in culture is highly effective in increasing the sensitivity of T lymphocyte proliferative assays.</description><identifier>ISSN: 1756-0500</identifier><identifier>EISSN: 1756-0500</identifier><identifier>DOI: 10.1186/1756-0500-7-662</identifier><identifier>PMID: 25239080</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Analysis ; Antigens ; Antigens - immunology ; Blood & organ donations ; Cell division ; Cell Proliferation ; Consent ; Cytokines ; Females ; Humans ; Immunologic Memory ; Interleukin-2 - physiology ; Laboratories ; Lymphocytes ; Medical research ; Mitogens ; Studies</subject><ispartof>BMC research notes, 2014-09, Vol.7 (1), p.662-662, Article 662</ispartof><rights>COPYRIGHT 2014 BioMed Central Ltd.</rights><rights>2014 Kennell et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</rights><rights>Kennell et al.; licensee BioMed Central Ltd. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4962-9338cce0f616ce33125e169e1f7640ca3b521eb9cc9ed0def5e6dead7e6eb6093</citedby><cites>FETCH-LOGICAL-b4962-9338cce0f616ce33125e169e1f7640ca3b521eb9cc9ed0def5e6dead7e6eb6093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190572/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190572/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25239080$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kennell, Amy S M</creatorcontrib><creatorcontrib>Gould, Keith G</creatorcontrib><creatorcontrib>Salaman, Myer R</creatorcontrib><title>Proliferation assay amplification by IL-2 in model primary and recall antigen systems</title><title>BMC research notes</title><addtitle>BMC Res Notes</addtitle><description>It can be difficult to register a weak proliferative response of T lymphocytes to an antigen, particularly in a simple culture system of peripheral blood mononuclear cells (PBMC). Here we assess the usefulness of the cytokine IL-2 in amplifying such a response.
PBMC from healthy donors were cultured in the presence or absence of keyhole limpet haemocyanin (KLH), an antigen to which people have not been previously exposed. IL-2 was added from the beginning or on the fifth day of culture. Proliferation was determined by incorporation of tritiated thymidine at eight days. The recall antigen, tuberculin PPD, provided a positive control.
IL-2 added at the beginning of culture can induce extremely high levels of proliferation even in the absence of antigen. However, when added on the fifth day it allowed the clear observation of a proliferative response to KLH that was barely detectable in its absence. Added late it was similarly able to boost low responses to PPD and to the mitogens lipopolysaccharide and poly(I:C), but it had no such effect with pokeweed mitogen.
IL-2 added late in culture is highly effective in increasing the sensitivity of T lymphocyte proliferative assays.</description><subject>Analysis</subject><subject>Antigens</subject><subject>Antigens - immunology</subject><subject>Blood & organ donations</subject><subject>Cell division</subject><subject>Cell Proliferation</subject><subject>Consent</subject><subject>Cytokines</subject><subject>Females</subject><subject>Humans</subject><subject>Immunologic Memory</subject><subject>Interleukin-2 - physiology</subject><subject>Laboratories</subject><subject>Lymphocytes</subject><subject>Medical research</subject><subject>Mitogens</subject><subject>Studies</subject><issn>1756-0500</issn><issn>1756-0500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kk1v1DAQhi0EoqVw5oYicYFDWn_EjnNBKlWBlVYqB8rVcpzJ4sqxFztB7L-vo12WBhX54NHMM69Hrweh1wSfEyLFBam5KDHHuKxLIegTdHrMPH0Qn6AXKd1hLIiU5Dk6oZyyBkt8im6_xuBsD1GPNvhCp6R3hR62OWfNPtfuitW6pIX1xRA6cMU22kHHjPmuiGC0czkc7QZ8kXZphCG9RM967RK8Otxn6PbT9berL-X65vPq6nJdtlUjaNkwJo0B3AsiDDBGKAciGiB9LSpsNGs5JdA2xjTQ4Q56DqID3dUgoBW4YWfow153O7UDdAb8GLVThwFV0FYtK97-UJvwS1WkwbymWeDjXqC14T8Cy4oJg5ptVbOtqlbZ9Czy7jBFDD8nSKMabDLgnPYQpqQIl4Jgysk88Nt_0LswRZ89ylSdv0XWnP2lNtqBsr4P-W0zi6pLXmHJqkqKTJ0_QuXTwWBN8NDbnF80vF80ZGaE3-NGTymp1c33JXuxZ00MKUXoj54QrObVe8SFNw__4sj_2TV2D87h0uw</recordid><startdate>20140920</startdate><enddate>20140920</enddate><creator>Kennell, Amy S M</creator><creator>Gould, Keith G</creator><creator>Salaman, Myer R</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140920</creationdate><title>Proliferation assay amplification by IL-2 in model primary and recall antigen systems</title><author>Kennell, Amy S M ; Gould, Keith G ; Salaman, Myer R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4962-9338cce0f616ce33125e169e1f7640ca3b521eb9cc9ed0def5e6dead7e6eb6093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analysis</topic><topic>Antigens</topic><topic>Antigens - immunology</topic><topic>Blood & organ donations</topic><topic>Cell division</topic><topic>Cell Proliferation</topic><topic>Consent</topic><topic>Cytokines</topic><topic>Females</topic><topic>Humans</topic><topic>Immunologic Memory</topic><topic>Interleukin-2 - physiology</topic><topic>Laboratories</topic><topic>Lymphocytes</topic><topic>Medical research</topic><topic>Mitogens</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kennell, Amy S M</creatorcontrib><creatorcontrib>Gould, Keith G</creatorcontrib><creatorcontrib>Salaman, Myer R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC research notes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kennell, Amy S M</au><au>Gould, Keith G</au><au>Salaman, Myer R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proliferation assay amplification by IL-2 in model primary and recall antigen systems</atitle><jtitle>BMC research notes</jtitle><addtitle>BMC Res Notes</addtitle><date>2014-09-20</date><risdate>2014</risdate><volume>7</volume><issue>1</issue><spage>662</spage><epage>662</epage><pages>662-662</pages><artnum>662</artnum><issn>1756-0500</issn><eissn>1756-0500</eissn><abstract>It can be difficult to register a weak proliferative response of T lymphocytes to an antigen, particularly in a simple culture system of peripheral blood mononuclear cells (PBMC). Here we assess the usefulness of the cytokine IL-2 in amplifying such a response.
PBMC from healthy donors were cultured in the presence or absence of keyhole limpet haemocyanin (KLH), an antigen to which people have not been previously exposed. IL-2 was added from the beginning or on the fifth day of culture. Proliferation was determined by incorporation of tritiated thymidine at eight days. The recall antigen, tuberculin PPD, provided a positive control.
IL-2 added at the beginning of culture can induce extremely high levels of proliferation even in the absence of antigen. However, when added on the fifth day it allowed the clear observation of a proliferative response to KLH that was barely detectable in its absence. Added late it was similarly able to boost low responses to PPD and to the mitogens lipopolysaccharide and poly(I:C), but it had no such effect with pokeweed mitogen.
IL-2 added late in culture is highly effective in increasing the sensitivity of T lymphocyte proliferative assays.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>25239080</pmid><doi>10.1186/1756-0500-7-662</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1756-0500 |
ispartof | BMC research notes, 2014-09, Vol.7 (1), p.662-662, Article 662 |
issn | 1756-0500 1756-0500 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4190572 |
source | MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
subjects | Analysis Antigens Antigens - immunology Blood & organ donations Cell division Cell Proliferation Consent Cytokines Females Humans Immunologic Memory Interleukin-2 - physiology Laboratories Lymphocytes Medical research Mitogens Studies |
title | Proliferation assay amplification by IL-2 in model primary and recall antigen systems |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A00%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proliferation%20assay%20amplification%20by%20IL-2%20in%20model%20primary%20and%20recall%20antigen%20systems&rft.jtitle=BMC%20research%20notes&rft.au=Kennell,%20Amy%20S%20M&rft.date=2014-09-20&rft.volume=7&rft.issue=1&rft.spage=662&rft.epage=662&rft.pages=662-662&rft.artnum=662&rft.issn=1756-0500&rft.eissn=1756-0500&rft_id=info:doi/10.1186/1756-0500-7-662&rft_dat=%3Cgale_pubme%3EA540834486%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1572528753&rft_id=info:pmid/25239080&rft_galeid=A540834486&rfr_iscdi=true |